180 related articles for article (PubMed ID: 6989572)
1. Prospective evaluation of some candidate tumor markers in the diagnosis of pancreatic cancer.
Mackie CR; Moossa AR; Go VL; Noble G; Sizemore G; Cooper MJ; Wood RA; Hall AW; Waldmann T; Gelder F; Rubenstein AH
Dig Dis Sci; 1980 Mar; 25(3):161-72. PubMed ID: 6989572
[TBL] [Abstract][Full Text] [Related]
2. Clinical and hormonal aspects of the watery diarrhea-hypokalemia-achlorhydria (WDHA) syndrome due to vasoactive intestinal polypeptide (VIP)-producing tumor.
Yamaguchi K; Abe K; Adachi I; Tanaka M; Ueda M; Oka Y; Miyakawa S; Kameya T; Yanaihara N
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():79-86. PubMed ID: 7014208
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between fasting glycemia, serum peptide C, insulin, growth hormone and plasma glucagon in acromegaly].
Piniewska-Hułas D; Lewandowski Z; Kasperska-Dworak A; Bonicki W
Pol Arch Med Wewn; 1996 Jun; 95(6):524-33. PubMed ID: 9005421
[TBL] [Abstract][Full Text] [Related]
4. Peptide hormones in patients with lung cancer.
Hansen M; Bork E
Recent Results Cancer Res; 1985; 99():180-6. PubMed ID: 2999917
[No Abstract] [Full Text] [Related]
5. Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
Prinz RA; Bermes EW; Kimmel JR; Marangos PJ
Surgery; 1983 Dec; 94(6):1019-23. PubMed ID: 6196846
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of peptide hormones LH, FSH, TSH, prolactin, HCG, parathormone, calcitonin and prostaglandin F2 alpha in kidney neoplasms].
Dunzendorfer U; Drahovsky D; Schmidt-Gayk H; Zahradnik HP
Z Urol Nephrol; 1981 Jan; 74(1):13-9. PubMed ID: 6785940
[TBL] [Abstract][Full Text] [Related]
7. Ribonucleases and deoxyribonucleases in pancreatic cancer: clinical value and pathophysiological interrelationships.
Del Favero G; Basso D; Fabris C; Angonese C; Meani A; Vianello D; Pedrazzoli S; Dodi G; Naccarato R
Int J Pancreatol; 1988; 3 Suppl 1():S107-12. PubMed ID: 3209863
[TBL] [Abstract][Full Text] [Related]
8. ERCP and serum alkaline phosphatase in pancreatic carcinoma.
Seligson U; Söderlund C
Acta Chir Scand; 1986 Apr; 152():309-12. PubMed ID: 3739538
[TBL] [Abstract][Full Text] [Related]
9. Hormone studies in health and disease using radioimmunological assay.
Greenwood FC; Landon J
Prog At Med; 1968; 2():1-38. PubMed ID: 4947474
[No Abstract] [Full Text] [Related]
10. Combined evaluation of serum ribonuclease and ferritin: any advantages in pancreatic cancer diagnosis?
Fabris C; Farini R; Del Favero G; Grassi F; Nitti D; Piccoli A; Brosolo P; Naccarato R
Oncology; 1984; 41(6):393-5. PubMed ID: 6504493
[TBL] [Abstract][Full Text] [Related]
11. [Regulation of endocrine secretion in a case of polyadenomatosis].
Heynen GO; Luyckx A; Franchimont P; Van Cauwenberge H
Actual Endocrinol (Paris); 1973; 13(0):275-87. PubMed ID: 4152415
[No Abstract] [Full Text] [Related]
12. Gastrointestinal/pancreatic hormone concentrations in the portal venous system of nine patients with organic hyperinsulinism.
Glaser B; Valtysson G; Fajans SS; Vinik AI; Cho K; Thompson N
Metabolism; 1981 Oct; 30(10):1001-10. PubMed ID: 6116152
[TBL] [Abstract][Full Text] [Related]
13. Characteristic changes in the concentrations of some peptide hormones, in particular those regulating serum calcium, in acute pancreatitis and myocardial infarction.
de Boer AC; Mulder H; Fischer HR; Schopman W; Hackeng WH; Silberbusch J
Acta Med Scand; 1981; 209(3):193-8. PubMed ID: 7013427
[TBL] [Abstract][Full Text] [Related]
14. The use of carcinoembryonic antigen and peptide hormones to stage and monitor patients with lung cancer.
Gropp C; Havemann K; Scheuer A
Int J Radiat Oncol Biol Phys; 1980 Aug; 6(8):1047-53. PubMed ID: 6252125
[No Abstract] [Full Text] [Related]
15. Gastrinemia, serum minerals and calciotropic hormones following highly selective vagotomy in duodenal ulcer patients. Results of a 1-year study.
Schwille PO; Mühe E; Gentsch H; Schellerer W; Scholz D
Hepatogastroenterology; 1980 Apr; 27(2):121-9. PubMed ID: 7216125
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin, parathyroid hormone and insulin concentrations in sera from patients with gastrinoma.
Cecchettin M; Albertini A; Bonora G; Vezzadini P
Adv Exp Med Biol; 1978; 106():117-9. PubMed ID: 717155
[No Abstract] [Full Text] [Related]
17. A prospective multicenter trial evaluating diagnostic validity of multivariate analysis and individual serum marker in differential diagnosis of pancreatic cancer from benign pancreatic diseases.
Hayakawa T; Naruse S; Kitagawa M; Ishiguro H; Kondo T; Kurimoto K; Fukushima M; Takayama T; Horiguchi Y; Kuno N; Noda A; Furukawa T
Int J Pancreatol; 1999 Feb; 25(1):23-9. PubMed ID: 10211418
[TBL] [Abstract][Full Text] [Related]
18. C-peptide pattern in patients with pancreatic cancer.
Fogar P; Basso D; Panozzo MP; Del Favero G; Briani G; Fabris C; D'Angeli F; Meggiato T; Ferrara C; Plebani M
Anticancer Res; 1993; 13(6B):2577-80. PubMed ID: 8135497
[TBL] [Abstract][Full Text] [Related]
19. Biochemical procedures in different forms of cancer.
Schwartz MK
Med Clin North Am; 1971 May; 55(3):613-24. PubMed ID: 4325094
[No Abstract] [Full Text] [Related]
20. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
